LSD as an agonist of dopamine receptors in the striatum.
D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D003342:Corpus Striatum / Q000378:metabolism*; D004027:Diencephalon / Q000502:physiology; D004298:Dopamine / Q000378:metabolism*; D004305:Dose-Response Relationship, Drug; D006220:Haloperidol / Q000494:pharmacology; D006892:Hydroxydopamines; D008238:Lysergic Acid Diethylamide / Q000494:pharmacology*; D008297:Male; D009043:Motor Activity / Q000187:drug effects; D009410:Nerve Degeneration; D051381:Rats; D011955:Receptors, Drug; D012701:Serotonin; D013687:Telencephalon / Q000502:physiology
D006892:Hydroxydopamines; D011955:Receptors, Drug; D012701:Serotonin; D008238:Lysergic Acid Diethylamide; D006220:Haloperidol; D004298:Dopamine